Skip to the page content
Your donations
Passes our checks

American Society for Transplantation & Cellular Therapy

EIN 52-1850793 · Chicago, IL

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthGood83 out of 100GovernanceGood77 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

ASTCT IS AN INTERNATIONAL PROFESSIONAL MEMBERSHIP ASSOCIATION OF MORE THAN 3000 PHYSICIANS, INVESTIGATORS AND OTHER HEALTH CARE PROFESSIONALS FROM MORE THAN 45 COUNTRIES, WHO ARE DEDICATED TO IMPROVING THE APPLICATION AND SUCCESS OF BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES. ASTCT STRIVES TO BE THE LEADING ORGANIZATION PROMOTING RESEARCH, EDUCATION AND CLINICAL PRACTICE IN THE FIELD THROUGH PROMOTING: COMPREHENSIVE DEVELOPMENT AND ADVANCEMENT OF THE FIELD OF BLOOD AND MARROW TRANSPLANTATION; EXCELLENCE IN CLINICAL CARE AND TREATMENT OUTCOMES THROUGH STANDARDS FOR BLOOD AND MARROW TRANSPLANTATION; INNOVATIVE RESEARCH TO ADVANCE THE SCIENCE AND CLINICAL APPLICATIONS OF OTHER CELLULAR THERAPIES; AND, RAPID DISSEMINATION OF BASIC AND CLINICAL BMT RESEARCH FINDINGS WITHIN THE MEDICAL FIELD AND TO THE GENERAL PUBLIC.

Income
$8.5 million
Spending
$8.5 million
Spent on programs
94%
Reserves
12.6 months of spending
Largest source of income
fees for its services, 57%
Employees
0
Volunteers
25
Highest pay
$30,500, until 2/2024, then pres elect

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Good: 83 out of 100. Higher than 49% of charities in its peer group (medical research, $1m to $10m).

  • Reserves

    35 of 35

    Spendable reserves would cover 12.6 months of spending.

  • Debt

    10 of 20

    It owes 34% of what it owns.

  • Living within its means

    8 of 15

    Spending exceeded income by 0% of income.

  • Income trend

    15 of 15

    Income rose 5% on the year before.

  • Spending floor

    15 of 15

    93% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 77 out of 100. Higher than 26% of charities in its peer group (medical research, $1m to $10m).

  • Independent board

    25 of 25

    14 of 15 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Pay set independently

    0 of 5

    Reports no independent review process for its chief executive's pay.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (7)
  1. $2.5 million spent. ANNUAL MEETING - ASTCT TYPICALLY HOLDS A GENERAL MEETING WITH THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH ("CIBMTR"), WHERE ADMINISTRATORS, CLINICIANS, DATA MANAGER/CLINICAL RESEARCH PROFESSIONALS, FELLOWS IN TRAINING, INVESTIGATORS, LABORATORY TECHNICIANS, MEDICAL DOCTORS, NURSES, NURSE PRACTITIONERS, PHARMACISTS, PHYSICIAN ASSISTANTS, AND OTHER ALLIED HEALTH PROFESSIONALS BENEFIT FROM A FULL SCIENTIFIC PROGRAM; ADDRESSING THE MOST TIMELY ISSUES IN HEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY.
  2. $2.0 million spent. EDUCATION AND CONFERENCES - ASTCT PROVIDES FOCUSED EDUCATION TO IMPROVE RESEARCH, PATIENT OUTCOMES, AND FOSTER PROFESSIONAL DEVELOPMENT THROUGH DIVERSE OUTLETS AND OPPORTUNITIES.
  3. $666,903 spent. OTHER PROGRAMS - THROUGHOUT THE YEAR, ASTCT OFFERS SPONSORSHIPS IN SUPPORT OF VARIOUS FUNCTIONS, INCLUDING ITS CONTENT HUB. SPONSORSHIP ARE RECOGNIZED RATABLY OVER THE APPLIABLE PERIOD. ASTCT ALSO RECEIVES A LIMITED AMOUNT OF REVENUES FROM ACTIVITIES, WHICH ARE RECOGNIZED AT A POINT IN TIME IN WHICH THE RELATED PERFORMANCE OBLIGATIONS ARE FULFILLED.
  4. $542,978 spent. JOURNAL AND PUBLICATIONS - ASTCT RECEIVES ROYALTIES ON ADVERTISEMENT SALES AND OTHER SOURCES OF REVENUE ASSOCIATED WITH ITS JOURNAL, TRANSPLANTATION AND CELLULAR THERAPY, AS WELL AS CERTAIN EDITORIAL SUBSIDIES, UNDER A COLLABORATIVE ARRANGEMENT WITH ELSEVIER, INC.
  5. $730,148 spent. MEMBERSHIP - ASTCT MEMBERS SPAN THE ENTIRE FIELD OF TRANSPLANTATION AND CELLULAR THERAPY - FROM BASIC SCIENCE RESEARCH TO DIRECT PATIENT CARE. ASTCT OFFERS A VARIETY OF MEMBERSHIP TYPES; INCLUDING AFFILIATE, JOINT, ASSOCIATE, HONORARY, IN-TRAINING, INTERNATIONAL, AND INSTITUTIONAL.
  6. $669,676 spent. POLICY AND LEGISLATIVE - ASTCT PROUDLY ADVOCATES ON BEHALF OF ITS MEMBERS AND PATIENTS BY ENGAGING WITH GOVERNMENT LEADERS ON CAPITOL HILL AND SUBMITTING RESPONSES TO IMPORTANT LEGISLATIVE AND POLICY CHANGES. ASTCT BELIEVES THAT ADVOCACY IS A KEY COMPONENT IN SERVING PATIENTS BY HELPING THEM TO ACCESS SOME OF THE MOST INNOVATIVE LIFESAVING TREATMENTS
  7. $815,050 spent. INDUSTRY SUPPORT - ASTCT SPONSORS "NEW INVESTIGATOR AWARDS" AS PART OF ITS INDUSTRY RELATION PROGRAM DESIGNED TO ENCOURAGE CLINICAL AND/OR LABORATORY RESEARCH BY YOUNG INVESTIGATORS IN THE FIELD OF BLOOD AND MARROW TRANSPLANTATION, AND/OR CELL THERAPY.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 1994.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.